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SHORT COMMUNICATION  
TRANSFUSION-RELATED ACUTE LUNG INJURY IN A PAEDIATRIC 
INTENSIVE CARE UNIT OF PAKISTAN 
Muhammad Tariq Jamil, Zehra Dhanani, Qalab Abbas, Humaira Jurair, Farheen Karim 
Mahar*, Anwarul Haque 
Department of Paediatrics & Child Health, *Department of Pathology, Aga Khan University Hospital Karachi-Pakistan 
Background: Transfusion-Related Acute Lung Injury (TRALI) is a major cause of transfusion-
related morbidity and mortality in the intensive care unit setting. There is a paucity of such data 
from Pakistan. The purpose of this study is to assess the incidence and outcome of TRALI in 
critically ill children admitted in a pediatric intensive care unit (PICU) of Pakistan. Methods: This 
is a retrospective cohort study of all critically ill or injured children who developed TRALI or 
“possible” TRALI after blood transfusion based on Canadian Conference Consensus criteria in a 
closed multidisciplinary-cardiothoracic PICU from January 2012 to June 2016. The demographic, 
pertinent clinical data, transfusion-related variables and outcome of all cases of TRALI were recorded. 
Results: Of total 2975 admissions in the PICU during study period, 35.8% (1066) received 5124 blood 
components. Eleven cases developed TRALI in our cohort. The incidence of TRALI was 1.03% per 
patient transfused and 0.19% (19/100,000 per blood product transfused). Median age was 8 (range 1–14) 
yr., 70 % (n=8) were male. Mean PRISM-III score was 16.3±6.7. Mean time interval for onset of TRALI 
was 2.73±1.67 hr. The postoperative cardiac surgical and hematology-oncology patients were most 
common categories (63.6%). Plasma and platelets were the most commomly identified trigger of TRALI. 
The case-specific mortality was 63.6% and the overall mortality was 10.7% (p<0.0001). Conclusion: The 
incidence of TRALI in critically ill children is low, but is associated with high mortality. Critically ill 
children with high PRISM-III score, postoperative cardiac surgical and hematology-oncology patients are 
often affected by TRALI. 
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INTRODUCTION 
Blood product transfusion is a commonly employed 
life-saving procedure in critically sick patients. 
According to an estimate, around 49% of children 
admited in multidisciplinary paediatrics intensive 
care unit (PICU), received at least one blood product 
during their hospital stay. This percentage increased 
to 78% of children admitted in cardiac PICU.1,2  
Blood transfusion, however, is not free of 
risks and is associated with multiple known and 
emerging complications. These complications are 
broadly classified into infectious and non infectious 
complications. With the advent of proper screening 
practices, the incidence of tranfusion related 
infectious complications has significantly reduced.3 
The major burden of morbidity and mortality 
secondary to blood transfusion is largely accounted 
by the severe non infectious transfusion related 
complications.4 
Transfusion related acute lung injury 
(TRALI) is one such complication which is now 
emerging as the leading cause of tranfusion related 
morbidity and mortality. According to the definition 
proposed by Canadian Conference Consensus (CCC) 
and National Heart, Lung, and Blood Institute 
(NHLBI), TRALI is defined as an acute lung injury 
occurring during or within 6 h after a transfusion, 
with a clear temporal relationship to transfusion.5 The 
term “possible “ TRALI is used when TRALI occurs 
in the presence of alternate risk factor for acute lung 
injury such as cardiac surgery (cardiopulmonary 
bypass), severe sepsis, pneumonia, hematological 
malignancy and mechanical ventilation.6,7  
Since TRALI poses a major threat to post 
transfusion critically ill patients, it is extremley 
important to estimate the disease burden in order to 
take effective measures to prevent and treat it. 
Multiple studies have been conducted to report the 
incidence and overall disease outcome of TRALI in 
adult population. However, little data is available for 
the paediatric population.8,9 We therefore conducted 
this study to determine the incidence and  overall 
outcome of TRALI in critically ill children, in a 
tertiary care hospital. 
MATERIAL AND METHODS 
We retrospectively reviewed the medical record of all 
critically ill children who developed TRALI in closed 
multidisciplinary-cardiothoracic pediatric intensive 
care unit (PICU) of Aga Khan University Hospital 
(AKUH) from January 2012 to June 2016. AKUH is 
a tertiary-care, university hospital with 8-beded 
multidisciplinary and cardiothoracic intensive care 
unit with annual admission of around 600 patients. 
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The blood bank of the hospital is manned by a team 
of experienced and fully trained medical 
technologists who work under the supervision of full-
time hematologists to provide quality service round 
the clock. AKUH is a Joint Commission International 
accredited hospital and our laboratory is certified by 
College of American Pathologists (CAP). We follow 
strict transfusion policy in our unit.10 and we 
preferentially used male-donor plasma in our PICU. 
Like other acute transfusion reactions, all cases of 
TRALI are reported to the blood bank. Blood bank 
completes transfusion reaction investigation by 
reviewing patient history and following up on donors 
and products implicated in each case.  
The case definition of TRALI was used 
based on CCC criteria and TRALI was defined as 
of acute dyspnea with hypoxia and bilateral 
pulmonary infiltrates on chest X-ray during or 
within six hours of end of blood transfusion in the 
absence of other causes of acute lung injury. The 
“possible” TRALI was defined as TRALI in the 
presence of risk factor for acute lung injury. The 
medical record of children (aged 1 month to 16 
years) with TRALI was retrieved by using ICD-9: 
518.7 code from our medical record.6 Data for the 
total number and type of blood components was 
retrieved from blood bank record. The following 
data was collected on structured performa: 
demographic variables (age, gender), clinical 
variables (diagnosis, PRISM -III score11, time of 
onset hypoxia, need for respiratory support, length 
of stay and use of inotropes), transfusion-related 
data (number and type of blood components) and 
outcome (defined as death or survival of the 
patient). Descriptive statistics were applied for 
data analysis. This study was approved by local 
institutional Ethical Review Committee [4463-Ped-
ERC-16]. 
RESULTS  
Out of total 2975 patients admitted to the PICU 
during the study period, 35.8% (n=1066) received at 
least one or more blood component transfusion. 
Forty-one percent (n=1145) were post-cardiac 
surgical patients. Total number of blood components 
transfused was 5,727 which included: 1759 (30.7%) 
packed red blood cells, 2226 (38.9%) fresh frozen 
plasma, 459 (8%) cryoprecipitate, 1279 (22.3%) 
platelets and 4 whole blood (0.07%). Eleven patients 
(1.03% per patient transfused) developed TRALI 
during the study period. The incidence of TRALI per 
100,000 blood components transfused was 
19/100,000 (0.19%). The demographic, clinical, 
transfusion-related characteristics and outcome are 
described in table-1. 
Median age of patients was 8 (range 1–16) 
years including 8 males and 3 female patients. The 
mean PRISM-III score was 16.36 (SD 6.77) and the 
mean time interval to development of TRALI was 
2.73 (SD 1.67) hours. All of them were severely 
hypoxic and demonstrated as mean PaO2: FiO2 ratio 
of 88.72 (SD 72.78). Ten (90.9%) required 
mechanical ventilation and two patients were 
advanced to High Frequency Oscillatory Ventilation. 
Seven (63.63%) patients expired. One patient was not 
mechanically ventilated because of code status of 
“Do Not Resuscitate” (DNR). All of our cases were 
“possible TRALI” because other risk factors for acute 
lung injurywere present. There was a temporal rise in 
the incidence of TRALI over the duration of the 
study. All components of blood are implicated in the 
development of TRALI in our cohort. However, there 
was a predominance of plasma and platelets being 
implicated. The overall mortality of the PICU during 
the study period was 10.7% and case-specific 
mortality was 63.6% (p<0.0001). 
 
Table-1: The demographic, clinical, transfusion-related characteristics and outcome of patients who 
developed TRALI during stay in PICU at AKUH. 
Age 
(Years) 
Sex 
M/F 
PRISM-
III Score 
DIAGNOSIS Year Trigger TIME 
(hours) 
PaO2/FiO2 
Ratio 
Mechanical 
Ventilation 
Outcome 
(A/E) 
10 F 12 Atypical HUS 2012 FFP 3 54 Y A 
6 M 20 S/P Rastelli 2014 WB 1 47 Y E 
11 M 11 AML 2015 PC 1 104 Y E 
1 F 24 Septic Shock 2015 FFP 5 40 Y+HFO E 
9 M 23 THAL, BMT 2015 PLT 2 82 Y+HFO E 
13 M 13 Aplastic Anemia 2013 PLT 5 165 Y E 
2 F 13 SP TOF Repair 2013 CRYO 2 42 Y E 
3 M 14 SP TOF Repair 2014 CRYO 1 51 Y A 
1 F 10 Pneumonia 2016 PC 5 45 Y E 
8 M 15 SP TOF Repair 2016 Mixed 3 51 Y A 
14 M 25 Aplastic Anemia 2016 PLT 3 214 Y A 
Abbreviation: Y-yes; A-alive; E-expired 
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DISCUSSION 
With this study, we report eleven cases of TRALI 
admitted in multidisciplinary and cardiothoracic 
PICU in a tertiary care hospital of Pakistan.  
TRALI, although less common, is now 
emerging as a leading non infectoius complication of 
blood product transfusion. There is paucity of clinical 
data on TRALI in the pediatric population  and it is 
mainly limited to case reports, case series and 
hemovigilance reporting systems.8,12 According to the 
hemovigilence reports from UK and Canada, the 
incidence of TRALI in paediatric population is about 
6% of all the adverse reactions post blood 
transfusion.11,13 A study conducted in 2015, reported 
the incidence of TRALI in of about 6.9% per 
transfused patient and 1.5% per product transfused 
over a period of four years in PICU settings.9 
The incidence of TRALI in our 
heterogeneous cohort was found to be 1.03% per 
transfused patient and 0.19% per transfused unit of 
blood. The stark variation in our estimates and what 
has been previously establishedis of note.9 TRALI in 
general is an underdiagnosed and under reported 
condition.14 We have a universally accepted 
definition for TRALI in adult population however no 
set criterean exists for the paediatric population.15–17 
These discrepencies in guidelines and overall under 
detectection of the disease leads to lesser people 
being diagnosed, which could also be attributed to the 
lower incidence in our cohort. Another factor that 
could have led to lower incidence in our cohort is the 
preferential use of male donor plasma, which has 
been previously associated with a reduction in the 
incidence of TRALI.18 
The rate of blood transfusion in our cohort is 
higher (35.8%) than what has been reported 
previously.9 This is most likely due to a higher 
proportion of cardiac post operative surgery patients 
in our study. Such patients are predispoed to 
complications like coagulopathy and thus have higher 
transfussion requirements.2 
We did not find any age predilection in our 
cohort and our patients were distributed across all age 
groups. This was in contrast to a bimodal age of 
presentation, as previously demonstrated in a study.9 
We observed TRALI events from all components of 
blood including whole blood. The risk of TRALI was 
higher with plasma and platelets than RBC or whole 
blood, similar to what has been reported previously.19 
All of our PICU patients had high PRISM-III scores, 
with a mean of 16.36, which put them at risk of 
developing acute lung injury due to multiple other 
factors and were thus labelled as “possible” TRALI.  
About two-third of our cohort were either 
postoperative cardiac surgical or hemotology-
oncolgy patients, who have an increased rate of 
transfussion, as mentioned.22 These patients have co 
morbids like cardiac bypass, sepsis and pneumonia, 
which in turn puts them at risk to develop acute lung 
injury. However, these risk factors also support “two-
event” hypothesis in the pathogenesis of TRALI, 
where the first event is the presence of critical illness 
and blood transfusion serves as the second event.20 
The mortality rate of patients with TRALI 
was higher (63.7%) than the overall mortality rate 
(10.7%) in our cohort (p<0.0001). This finding was 
in accordance to what has been demonstrated 
previously; where TRALI was associated with high 
mortality rate both in adult and paediatric population 
(63.7%). 
This is first such study from Pakistan to 
report the incidence of TRALI and its outcomes from 
a tertiary care hospital based PICU with 
multidisciplinary patients. Some of the weaknesses of 
our study include it being a retrospective study based 
on patients from a single center. We were also unable 
to establish a an association between the volume of 
blood being transfused and development of TRALI. 
CONCLUSION 
We found that the incidence of TRALI in critically ill 
children is lower than previously reported, but is 
associated with a high mortality rate. Critically ill 
children with high PRISM-III score, postoperative 
cardiac surgical and hematology-oncology patients 
have the higher likelyhood of getting affected by 
TRALI. 
AUTHORS' CONTRIBUTION  
MTJ: Conception of idea, manuscript writing; ZD: 
data collection; QA and HJ review manuscript; FKM: 
Transfusion Specialist critical review; AH: Guarantor 
of manuscript  
REFERENCES 
1. Bateman ST, Lacroix J, Boven K, Forbes P, Barton 
R, Thomas NJ, et al. Anemia, blood loss, and blood 
transfusions in North American children in the intensive care 
unit. Am J Respir Crit Care Med 2008;17891):26–33. 
2. Mazine A, Rached-D'Astous S, Ducruet T, Lacroix J, Poirier 
N. Blood Transfusions After Pediatric Cardiac Operations: A 
North American Multicenter Prospective Study. Ann Thorac 
Surg 2015;100(2):671–7. 
3. Moiz B, Sharif H, Bawany FA. Transfusion related acute 
lung injury--TRALI: an under diagnosed entity. J Pak Med 
Assoc 2009;59(1):39–41. 
4. Hendrickson JE, Hillyer CD. Noninfectious serious hazards 
of transfusion. Anesth Analg 2009;108(3):759–69. 
5. Popovsky MA, Moore SB. Diagnostic and pathogenetic 
considerations in transfusion-related acute lung injury. 
Transfusion 1985;25(5):573–7. 
6. Kleinman S, Caulfield T, Chan P, Davenport R, McFarland 
J, McPhedran S, et al. Toward an understanding of 
J Ayub Med Coll Abbottabad 2017;29(4) 
http://www.jamc.ayubmed.edu.pk 705
transfusion-related acute lung injury: statement of a 
consensus panel. Transfusion 2004;44(2):1774–89.  
7. Toy P,  Popovsky MA, Abraham E, Ambruso DR, Holness 
LG, Kopko PM, et al. Transfusion-related acute lung injury: 
definition and review. Crit Care Med 2005;33(4):721–6. 
8. Dotis J,  Stabouli S, Violaki A, Vogiatzi L, Mitroudi 
M, Oikonomou M, et al. Transfusion-related acute lung 
injury management in a pediatric intensive care unit. 
Hippokratia 2011;15(2):184–6. 
9. Mulder HD, Augustijn QJ, van Woensel JB, Bos 
AP, Juffermans NP, Wösten-van Asperen RM. Incidence, 
risk factors, and outcome of transfusion-related acute lung 
injury in critically ill children: a retrospective study. J Crit 
Care 2015;30(1):55–9. 
10. Gauvin F,  Robillard P, Hume H, Grenier D, Whyte 
RK, Webert KE, et al. Transfusion-related acute lung injury 
in the Canadian paediatric population. Paediatr Child Health 
2012;17(5):235–9. 
11. Pollack MM, Patel KM, Ruttimann UE. PRISM III: an 
updated Pediatric Risk of Mortality score. Crit Care Med 
1996;24(5):743–52.  
12. Lieberman L, Petraszko T, Yi QL, Hannach B, Skeate R. 
Transfusion-related lung injury in children: a case series and 
review of the literature. Transfusion 2014;54(1):57–64. 
13. Stainsby D, Jones H, Wells AW, Gibson B, Cohen H. 
Adverse outcomes of blood transfusion in children: analysis 
of UK reports to the serious hazards of transfusion scheme 
1996-2005. Br J Haematol 2008;141(1):73–9. 
14. Wallis JP. Transfusion-related acute lung injury (TRALI)--
under-diagnosed and under-reported. Br J Anaesth 
2003;90(5)573–6. 
15. Marik PE, Corwin HL. Acute lung injury following blood 
transfusion: expanding the definition. Crit Care Med 
2008;36(11):3080–4. 
16. Pediatric acute Lung Injury Consensus Conference Group. 
Pediatric acute respiratory distress syndrome: consensus 
recommendations from the Pediatric Acute Lung Injury 
Consensus Conference. Pediatr Crit Care Med 
2015;16(5):428–39. 
17. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson 
ND, Caldwell E, Fan E, et al. Acute respiratory distress 
syndrome: the Berlin Definition. JAMA 2012;307(23):2526–33. 
18. Muller MC,  van Stein D, Binnekade JM, van Rhenen 
DJ, Vlaar AP. Low-risk transfusion-related acute lung injury 
donor strategies and the impact on the onset of transfusion-
related acute lung injury: a meta-analysis. Transfusion 
2015;55(1):164–75. 
19. Khan H, Belsher J, Yilmaz M, Afessa B, Winters JL, Moore 
SB, et al. Fresh-frozen plasma and platelet transfusions are 
associated with development of acute lung injury in critically 
ill medical patients. Chest 2007;131(5):1308–14. 
20. Silliman CC, Boshkov LK, Mehdizadehkashi Z, Elzi 
DJ, Dickey WO, Podlosky L, et al. Transfusion-related acute 
lung injury: epidemiology and a prospective analysis of 
etiologic factors. Blood 2003;101(2):454–62. 
 
Received: 16 March, 2017 Revised: -- Accepted: 2 June, 2017 
Address for Correspondence:  
Muhammad Tariq Jamil, Department of Paediatrics & Child Health, Aga Khan University Hospital Karachi-Pakistan 
Email: tariqjamildr@hotmail.com
 
